Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge?Based Immunoassays for European Clinical Laboratories
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge?Based Immunoassays for European Clinical Laboratories
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
Bio-Techne?Launches Simple?Plex?Ultra-Sensitive?Assays on Ella?Platform to Enable?Femtogram-Level?Detection of Neurological Biomarkers
Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
SAGA Metals Reports Assays from R-0018 to R-0020 with Intercepts Including 49.51% Fe?O?, 6.56% TiO?, 0.374% V?O? from 2026 Drilling at Trapper South, Radar Critical Minerals Project in Labrador
Sirios Resources Inc. Closes Fully-Subscribed $25 Million Brokered LIFE Offering of Flow-Through Units and Units
RZOLV Reports Preliminary Bench-Scale Silver Recovery Results on Solar Panel Concentrate, Highlighting Opportunity for High-Value PV Recycling
